Daily Med News

Vision Benefits in GA With Complement Inhibitor, Regardless of AMD, Anti-VEGF

(MedPage Today) — MONTREAL — Geographic atrophy (GA) had a similar response to the complement inhibitor pegcetacoplan (Syfovre) whether concurrent with neovascular age-related macular degeneration (nAMD) or alone, data from a retina clinical…

Source: MedPage Today — Headlines

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]